Evaluation of the genome-informed risk assessment (GIRA) approach from eMERGE in an independent health system
Sandra Lapinska, Xinzhe Li, Ravi Mandla, Zhuozheng Shi, Veronica Tozzo, Alexander O. Flynn-Carroll, Marylyn DeRiggi Ritchie, Daniel James Rader, Penn Medicine Biobank, Bogdan Paşaniuc
This study evaluates the GIRA approach in a health system, finding 30.4% of patients labeled high-risk based on genomic data, with ancestry differences and social deprivation influences.
medRxiv · Apr 29, 2026 · PreprintGenetic & Genomic Medicine